Genetics of hypogammaglobulinemia: what do we really know?
- PMID: 19651503
- PMCID: PMC2761500
- DOI: 10.1016/j.coi.2009.07.003
Genetics of hypogammaglobulinemia: what do we really know?
Abstract
In the past, immunodeficiencies were categorized based on clinical and laboratory findings in the affected patient. Now we are more likely to define them based on the specific gene involved. One might expect this shift to increase the precision and clarity of diagnosis but in the last few years it has become increasingly clear that identification of a mutation in a specific gene may not tell the whole story. Some gene defects may reliably result in clinical disease, others may act as susceptibility factors that are more common in patients with immunodeficiency but can also be found in otherwise healthy individuals. Distinguishing between these two types of gene defects is essential for informative genetic counseling.
Figures
References
-
- Durandy A, Taubenheim N, Peron S, Fischer A. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Adv.Immunol. 2007;94:275–306. This review provides an excellent overview of genes involved in the various forms of hyper-IgM syndrome including AICDA (AID) and UNG. It addresses the role of these genes in class switch recombination and somatic hypermutation. - PubMed
-
- Dobbs AK, Yang T, Farmer D, Kager L, Parolini O, Conley ME. A hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J.Immunol. 2007;179:2055–2059. This paper and Ref 10 are the first descriptions of mutations in Igβ (CD79b), a transmembrane component of the B cell antigen receptor. The patients described in both papers had agammaglobulinemia; however the mutation reported in this paper is a hypomorphic mutation and the patient had a leaky defect in B cell development whereas the patient reported in Ref. 10 had a null mutation and a complete block in B cell development. - PubMed
-
- Devriendt K, Kim AS, Mathijs G, Frints SG, Schwartz M, Van Den Oord JJ, Verhoef GE, Boogaerts MA, Fryns JP, You D, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat.Genet. 2001;27:313–317. - PubMed
-
- Ancliff PJ, Blundell MP, Cory GO, Calle Y, Worth A, Kempski H, Burns S, Jones GE, Sinclair J, Kinnon C, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood. 2006;108:2182–2189. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
